Head of Biostatistics - Waltham, MA
1 week ago

Job description
, consectetur adipiscing elit. Nullam tempor vestibulum ex, eget consequat quam pellentesque vel. Etiam congue sed elit nec elementum. Morbi diam metus, rutrum id eleifend ac, porta in lectus. Sed scelerisque a augue et ornare.
Donec lacinia nisi nec odio ultricies imperdiet.
Morbi a dolor dignissim, tristique enim et, semper lacus. Morbi laoreet sollicitudin justo eget eleifend. Donec felis augue, accumsan in dapibus a, mattis sed ligula.
Vestibulum at aliquet erat. Curabitur rhoncus urna vitae quam suscipit
, at pulvinar turpis lacinia. Mauris magna sem, dignissim finibus fermentum ac, placerat at ex. Pellentesque aliquet, lorem pulvinar mollis ornare, orci turpis fermentum urna, non ullamcorper ligula enim a ante. Duis dolor est, consectetur ut sapien lacinia, tempor condimentum purus.
Access all high-level positions and get the job of your dreams.
Similar jobs
Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Our core business strategy combines our experienced leadership team with a discipl ...
1 week ago
Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Our core business strategy combines our experienced leadership team with a discipl ...
1 week ago
The company is seeking their first in-house Head of Biostatistics (Executive Director or Vice President level). The ideal candidate brings deep oncology expertise and thrives in small biotech environments. · Serve as the organization's senior statistical leader. · Lead the desig ...
1 month ago
+Shape the statistical strategy powering AI-accelerated drug development across a multi-asset clinical pipeline backed by top pharma. · ...
1 month ago
This is a next-generation biotech built around an AI-first vision for drug development. Backed by major pharma and top-tier investors, the company combines advanced machine learning, LLM-driven discovery, and deep clinical expertise to accelerate the end-to-end development cycle. ...
1 month ago
Head of Biostatistics [AI-Driven Biotech] · Compensation: $250,000 – $380,000 base + stock options · Company Type: AI-first Biotech · Locations: New York, NY; Boston, MA; San Francisco, CA; Raleigh, NC (Hybrid) · Impact: Shape the statistical strategy powering AI-accelerated d ...
4 hours ago
TA Head of Biostatistics, Neuroscience and Ophthalmology
Only for registered members
The race is on to speed up drug discovery and development to find answers for patients and their families. Your skills could be critical in helping our teams accelerate progress. · ...
2 weeks ago
TA Head of Biostatistics, Neuroscience and Ophthalmology
Only for registered members
Join our Biostatistics Neuroscience and Ophthalmology team as Global Head of Neuroscience and Ophthalmology TA Biostatistics. · ...
2 weeks ago
The Clinical Pharmacology and Quantitative Medicine group at GSK is a newly established organization dedicated to becoming a Centre of Excellence in Model-Informed Drug Development. The MIDD Lead applies modeling and simulation to inform drug development decisions. · Design & Exe ...
1 month ago
The Clinical Pharmacology and Quantitative Medicine (CPQM) group at GSK is dedicated to becoming a Centre of Excellence in Model-Informed Drug Development (MIDD). This role oversees integration and leads on the delivery of advanced modelling and simulation approaches. · ...
2 weeks ago
The MIDD Lead is a scientific and strategic leader who applies modelling and simulation to inform drug development decisions. · ...
2 weeks ago
Opportunity awaits those up to the challenge of developing transformative therapies across a broad range of debilitating diseases. · Summary · The Executive Director, Clinical Science is a senior enterprise leader accountable for scientific rigor, executional excellence, and orga ...
5 days ago
The Clinical Pharmacology and Quantitative Medicine (CPQM) group at GSK is a newly established organization dedicated to becoming a Centre of Excellence in Model-Informed Drug Development (MIDD). CPQM uniquely integrates expertise in clinical pharmacology, digital medicine, trans ...
1 month ago
Opportunity awaits those up to the challenge of developing transformative therapies across a broad range of debilitating diseases. · Summary: · The Executive Director, Clinical Science is a senior enterprise leader accountable for scientific rigor, executional excellence, and org ...
4 days ago
+ Opportunity awaits those up to the challenge of developing transformative therapies across a broad range of debilitating diseases. · ...
3 weeks ago
GSK seeks an outstanding leader in clinical development to join as VP Clinical Research Head (CRH), Nephrology within the Advanced Portfolio Unit. This represents a critical and senior role at GSK, with an opportunity to provide leadership across the full discovery and developmen ...
1 month ago
Executive Medical Director, Clinical Development, Advanced Pipeline Unit
Only for registered members
+ GSK seeks Executive Medical Director for Clinical Development of APU Respiratory assets. · Lead clinical development strategy from drug or program accountability including clinical components of Target Medicine Profile TMP leadership of clinical matrix team CMT. · Ensure cohes ...
1 month ago
Executive Medical Director, Clinical Development, Advanced Pipeline Unit
Only for registered members
GSK seeks an Executive Medical Director to provide clinical and scientific leadership for potential new indications in APU Respiratory. · Lead clinical development strategy from drug or program including accountability for clinical components of TMP. · Ensure cohesive and compreh ...
1 month ago
Site Name: USA - Massachusetts - Waltham, Stevenage, UK - London, USA - Pennsylvania - Pennsylvania Central · Posted Date: Feb · At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on ...
1 week ago
At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the immune system with cutting-edge technology ...
1 week ago